Thank you Hottod for your time compiling this post, highly appreciated.
I agree with your reasoning in regards to why big institutions haven't invested into this company. However, even in this COVID-19 market, the economy is inflated with money. You dont get any interest rates and you are bound to invest into the stock market to get a ROI. For a company who has a Phase 3 study running, patient advocacy group "investing" into the company with a substantial amount in relation to their capabilities (basically saying, we opt for this product) & the medical community supporting the development of the product, the lack of commitment from institutional investors worries me.
Is this something someone could bring up during the next General Shareholder Assembly? I am not living in Australia, hence I cannot ask the question myself.
ACADIA TALKS TROFINETIDE, page-66
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |